Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hutchison China MediTech Limited (HCM : NSDQ)
 
 • Company Description   
Hutchison China MediTech Limited researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech Limited is based in Hong Kong.

Number of Employees: 1,759

 
 • Price / Volume Information   
Yesterday's Closing Price: $9.58 Daily Weekly Monthly
20 Day Moving Average: 652,115 shares
Shares Outstanding: 172.91 (millions)
Market Capitalization: $1,656.44 (millions)
Beta: 1.12
52 Week High: $43.94
52 Week Low: $8.78
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -40.61% -33.11%
12 Week -64.23% -60.68%
Year To Date -72.69% -67.99%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
48TH FLOOR CHEUNG KONG CENTER 2 QUEEN`S ROAD CENTRAL
-
HONG KONG,K3 -
HKG
ph: 852-2128-1188
fax: 852-2128-1778
ir@hutch-med.com http://www.hutch-med.com
 
 • General Corporate Information   
Officers
Christian Lawrence Hogg - Chief Executive Officer
Chi Keung To - Chairman
Karen Jane - Chief Operating Officer
Chig Fung Cheng - Chief Financial Officer
Marek Krzysztof Kania - Executive President

Peer Information
Hutchison China MediTech Limited (BJCT)
Hutchison China MediTech Limited (CADMQ)
Hutchison China MediTech Limited (APNO)
Hutchison China MediTech Limited (UPDC)
Hutchison China MediTech Limited (IMTIQ)
Hutchison China MediTech Limited (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 44842L103
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 172.91
Most Recent Split Date: (:1)
Beta: 1.12
Market Capitalization: $1,656.44 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.44 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.59
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - -
12/31/21 - 3.89
09/30/21 - -
Quick Ratio
03/31/22 - -
12/31/21 - 3.77
09/30/21 - -
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -60.58
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 6.01
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - 8.43
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - -
 

Powered by Zacks Investment Research ©